Lineage Cell Therapeutics (LCTX) Selling, General & Administrative (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported Selling, General & Administrative of $5.22 million for Q2 2026, up 14.4% from $4.56 million a year earlier and up 2.6% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lineage Cell Therapeutics' Selling, General & Administrative came in at $19.35 million, up 6.1% year-over-year; for FY2025, it came in at $18.46 million, up 1.6% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $18.17 million in FY2024 (+5.0%), $17.3 million in FY2023 (-23.1%), $22.51 million in FY2022 (+23.6%) and $18.21 million in FY2021 (+17.0%).
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since Q2 2022.
- Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 4.7% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2022 (growth of 115.2%); the low point was Q1 2023 (a decline of 44.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.08 million (Q1 2026), $4.85 million (Q4 2025) and $4.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Lineage Cell Therapeutics | 227.62 Mn | 26.02 Mn | - | 5.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.22 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 4.85 Mn |
| Sep 30, 2025 | 4.19 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 4.86 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 5.27 Mn |
| Mar 31, 2022 | 8.47 Mn |
| Dec 31, 2021 | 4.42 Mn |
| Sep 30, 2021 | 5.32 Mn |
API Access
Lineage Cell Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();